Search Prime Grants

U54CA231630

Cooperative Agreement

Overview

Grant Description
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma.
Awardee
Duke University
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Durham, North Carolina 27710 United States
Geographic Scope
Single Zip Code
Related Opportunity
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 08/31/25 and the total obligations have increased 12% from $5,804,197 to $6,495,717.
Duke University was awarded Screening for Cys-Reactive Ligands to Target PAX3-FOXO1 Cooperative Agreement U54CA231630 worth $6,495,717 from National Cancer Institute in August 2020 with work to be completed primarily in Durham North Carolina United States. The grant has a duration of 5 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).

Status
(Complete)

Last Modified 9/5/24

Period of Performance
8/12/20
Start Date
8/31/25
End Date
100% Complete

Funding Split
$6.5M
Federal Obligation
$0.0
Non-Federal Obligation
$6.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA231630

Subgrant Awards

Disclosed subgrants for U54CA231630

Transaction History

Modifications to U54CA231630

Additional Detail

Award ID FAIN
U54CA231630
SAI Number
U54CA231630-2027402402
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
TP7EK8DZV6N5
Awardee CAGE
4B478
Performance District
NC-04
Senators
Thom Tillis
Ted Budd

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $12,345,664 100%
Modified: 9/5/24